Advertisement

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study

Ali T. Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyère Mahuzier, Brian Gadbaw and Yesim Aydinok

Data supplements

  • Document 1. Supplemental methods, tables, and figures (PDF 1.3 MB)

    Supplemental materials for Taher, et al.